Jiadi Luo

1.3k total citations
43 papers, 928 citations indexed

About

Jiadi Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jiadi Luo has authored 43 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Jiadi Luo's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Jiadi Luo is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Jiadi Luo collaborates with scholars based in China and United States. Jiadi Luo's co-authors include Songqing Fan, Yuting Zhan, Qiuyuan Wen, Juan Feng, Junmi Lu, Hongmei Zheng, Weiyuan Wang, Lina Xu, Sile Liu and Shuzhou Chu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Jiadi Luo

42 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiadi Luo China 17 699 320 165 142 116 43 928
Qiuyuan Wen China 21 801 1.1× 424 1.3× 245 1.5× 133 0.9× 153 1.3× 59 1.1k
Jinah Park South Korea 19 787 1.1× 185 0.6× 262 1.6× 112 0.8× 137 1.2× 32 1.1k
Hailing Lu China 19 603 0.9× 285 0.9× 286 1.7× 94 0.7× 136 1.2× 35 894
Chunyang Xing China 15 555 0.8× 365 1.1× 181 1.1× 156 1.1× 64 0.6× 28 809
Johanna Tuomela Finland 19 537 0.8× 179 0.6× 327 2.0× 188 1.3× 174 1.5× 49 984
Pan Chen China 15 593 0.8× 475 1.5× 175 1.1× 88 0.6× 76 0.7× 38 857
Haohai Zhang China 17 372 0.5× 291 0.9× 201 1.2× 87 0.6× 130 1.1× 27 784
Samuel J. Vidal United States 7 473 0.7× 217 0.7× 308 1.9× 73 0.5× 164 1.4× 12 798
Julian A. Gingold United States 17 702 1.0× 293 0.9× 244 1.5× 173 1.2× 125 1.1× 60 1.3k
Svetlana Avdulov United States 15 911 1.3× 148 0.5× 146 0.9× 87 0.6× 215 1.9× 20 1.2k

Countries citing papers authored by Jiadi Luo

Since Specialization
Citations

This map shows the geographic impact of Jiadi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiadi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiadi Luo more than expected).

Fields of papers citing papers by Jiadi Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiadi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiadi Luo. The network helps show where Jiadi Luo may publish in the future.

Co-authorship network of co-authors of Jiadi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jiadi Luo. A scholar is included among the top collaborators of Jiadi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiadi Luo. Jiadi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zheng, Hongmei, et al.. (2025). YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway. Cancer Cell International. 25(1). 112–112. 1 indexed citations
3.
Wang, Huilin, et al.. (2025). Unveiling immune resistance mechanisms in nasopharyngeal carcinoma and emerging targets for antitumor immune response: tertiary lymphoid structures. Journal of Translational Medicine. 23(1). 38–38. 2 indexed citations
4.
Liu, Wei, et al.. (2024). Case report: Primary sarcoma of the mandible with a novel SLMAP-BRAF fusion. Frontiers in Oncology. 14. 1369046–1369046. 1 indexed citations
5.
Ning, Yue, Hongmei Zheng, Yang Yang, et al.. (2023). YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer. International Journal of Biological Sciences. 19(8). 2458–2474. 18 indexed citations
6.
Zhan, Yuting, Weiyuan Wang, Haihua Wang, et al.. (2023). G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway. International Journal of Biological Sciences. 20(1). 94–112. 4 indexed citations
7.
Zhan, Yuting, Jiadi Luo, Yang Yang, et al.. (2022). YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma. Scientific Reports. 12(1). 3699–3699. 9 indexed citations
8.
Luo, Jiadi, Ying Zhou, Hongjing Zang, et al.. (2022). Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer. BMC Cancer. 22(1). 564–564. 5 indexed citations
9.
Yang, Yang, Hongmei Zheng, Yuting Zhan, et al.. (2022). Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer. Journal of Cancer. 13(13). 3434–3443. 62 indexed citations
10.
Liu, Sile, Weiyuan Wang, Yue Ning, et al.. (2022). Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer. Cell Death and Disease. 13(2). 129–129. 41 indexed citations
11.
Luo, Jiadi, Yang Yang, Sile Liu, et al.. (2022). Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection. PLoS ONE. 17(6). e0265465–e0265465. 6 indexed citations
12.
Yang, Yang, Jiadi Luo, Sile Liu, et al.. (2020). Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients. Cancer Biomarkers. 30(1). 85–94. 20 indexed citations
13.
Luo, Jiadi, Xiaojing An, Annabel A. Ferguson, et al.. (2019). Epigenetic Regulation of IL-17-Induced Chemokines in Lung Epithelial Cells. Mediators of Inflammation. 2019. 1–11. 20 indexed citations
14.
Lu, Junmi, Yuting Zhan, Juan Feng, Jiadi Luo, & Songqing Fan. (2018). MicroRNAs associated with therapy of non-small cell lung cancer. International Journal of Biological Sciences. 14(4). 390–397. 68 indexed citations
15.
Liu, Sile, Yuting Zhan, Jiadi Luo, et al.. (2018). Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer. Biomedicine & Pharmacotherapy. 111. 338–346. 45 indexed citations
16.
Zheng, Hongmei, Yuting Zhan, Sile Liu, et al.. (2018). The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications. Journal of Experimental & Clinical Cancer Research. 37(1). 226–226. 108 indexed citations
17.
Fan, Weibing, et al.. (2017). Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma. PLoS ONE. 12(10). e0185563–e0185563. 22 indexed citations
18.
19.
Li, Jiao, Qiuyuan Wen, Lina Xu, et al.. (2014). Fatty acid synthase–associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma. Human Pathology. 45(12). 2447–2452. 12 indexed citations
20.
Wen, Qiuyuan, Jiao Li, Weiyuan Wang, et al.. (2014). Increased Expression of Flotillin-2 Protein as a Novel Biomarker for Lymph Node Metastasis in Nasopharyngeal Carcinoma. PLoS ONE. 9(7). e101676–e101676. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiuyuan Wen Breakdown of academic impact, for papers by Jinah Park Breakdown of academic impact, for papers by Hailing Lu Breakdown of academic impact, for papers by Chunyang Xing Breakdown of academic impact, for papers by Johanna Tuomela Breakdown of academic impact, for papers by Pan Chen Breakdown of academic impact, for papers by Haohai Zhang Breakdown of academic impact, for papers by Samuel J. Vidal Breakdown of academic impact, for papers by Julian A. Gingold Breakdown of academic impact, for papers by Svetlana Avdulov
Rankless by CCL
2026